We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$441M
AUM Growth
+$91.2M
Cap. Flow
+$74.5M
Cap. Flow %
16.9%
Top 10 Hldgs %
24.04%
Holding
1,099
New
222
Increased
266
Reduced
262
Closed
55

Top Buys

Rank Stock Value
1
UBS icon
UBS Group
UBS
+$15.4M
2
STLA icon
Stellantis
STLA
+$9.9M
3
ALC icon
Alcon
ALC
+$7.77M
4
AMZN icon
Amazon
AMZN
+$6.64M
5
RACE icon
Ferrari
RACE
+$5.26M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.26%
2 Technology 13.6%
3 Financials 12.86%
4 Healthcare 10.91%
5 Industrials 10.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SMAR
801
DELISTED
Smartsheet Inc.
SMAR
$2.66K ﹤0.01%
36
+13
+57% +$811
EWY icon
802
iShares MSCI South Korea ETF
EWY
$22.7B
$2.54K ﹤0.01%
28
-38
-58% -$3.5K
EWT icon
803
iShares MSCI Taiwan ETF
EWT
$10B
$2.51K ﹤0.01%
39
-128,916
-100% -$8.02M
NVO
804
Novo Nordisk
NVO
$216B
$2.51K ﹤0.01%
58
HCAT icon
805
Health Catalyst
HCAT
$154M
$2.51K ﹤0.01%
45
-43
-49% -$2.29K
AAPL icon
806
PUT
Apple
AAPL
$4.89T
$2.49K ﹤0.01%
+160
New +$20.7K
KNX icon
807
Knight Transportation
KNX
$11.8B
$2.45K ﹤0.01%
49
ORLY icon
808
O'Reilly Automotive
ORLY
$72.4B
$2.36K ﹤0.01%
60
LIVN icon
809
LivaNova
LIVN
$4.3B
$2.35K ﹤0.01%
47
SSNC icon
810
SS&C Technologies
SSNC
$17.8B
$2.34K ﹤0.01%
32
-35
-52% -$2.56K
BPMC
811
DELISTED
Blueprint Medicines
BPMC
$2.23K ﹤0.01%
27
RSX
812
DELISTED
VanEck Russia ETF
RSX
$2.22K ﹤0.01%
77
-250,661
-100% -$6.88M
THD icon
813
iShares MSCI Thailand ETF
THD
$361M
$2.18K ﹤0.01%
29
TRU icon
814
TransUnion
TRU
$14.8B
$2.13K ﹤0.01%
19
ILF icon
815
iShares Latin America 40 ETF
ILF
$3.77B
$2.07K ﹤0.01%
68
VAC icon
816
Marriott Vacations Worldwide
VAC
$3.24B
$2.02K ﹤0.01%
13
CERN
817
DELISTED
Cerner Corp
CERN
$1.99K ﹤0.01%
25
UHS icon
818
Universal Health Services
UHS
$9.43B
$1.99K ﹤0.01%
13
BBBY
819
DELISTED
Bed Bath & Beyond Inc
BBBY
$1.97K ﹤0.01%
+67
New +$1.86K
LTHM
820
DELISTED
Livent Corporation
LTHM
$1.95K ﹤0.01%
98
GEN icon
821
Gen Digital
GEN
$15.6B
$1.93K ﹤0.01%
71
TJX icon
822
TJX Companies
TJX
$170B
$1.89K ﹤0.01%
28
HUM icon
823
Humana
HUM
$46.7B
$1.84K ﹤0.01%
4
FLXN
824
DELISTED
Flexion Therapeutics, Inc.
FLXN
$1.82K ﹤0.01%
253
TSN icon
825
Tyson Foods
TSN
$20.2B
$1.79K ﹤0.01%
25

Similar funds

Exane Derivatives's Q2 2021 Portfolio in Review

As of Q2 2021, Exane Derivatives held 1,099 positions worth $441M, up 26% from $350M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Exane Derivatives deployed $74.5M of net new capital in Q2 2021, opening 222 new positions and adding to 266 existing holdings. Its largest new stake was Alcon: 109,041 shares worth $7.62M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares MSCI Taiwan ETF, an estimated $8.02M trimmed.

  • Exane Derivatives's largest Q2 2021 buy was Alcon: 109,041 shares worth $7.62M.
  • Exane Derivatives added most to UBS Group in Q2 2021, an estimated $15.4M increase.
  • Exane Derivatives's biggest Q2 2021 reduction was iShares MSCI Taiwan ETF, cutting an estimated $8.02M.
  • Exane Derivatives fully exited Deutsche Bank in Q2 2021, selling an estimated $4.27M.
  • Exane Derivatives's ten largest holdings make up 24% of its $441M portfolio in Q2 2021.
  • Exane Derivatives opened 222 new positions and closed 55 in Q2 2021.
  • Exane Derivatives's portfolio value rose 26% quarter-over-quarter to $441M.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.